Cogent Biosciences (COGT) - Net earnings per share (EPS TTM)

Symbol and logo of brand cogentbio.com (COGT)

Cogent Biosciences profitability is independent of market cycles, relying instead on a strict schedule of scientific research. The rolling annual net income per share visualizes revenue dynamics, where the value -2.49 represents the current figure. Successes with bezuklastinib and FDA approval are driving the stock price higher, although high R&D costs in the absence of revenue create significant cash pressure on capital.

COGT (cogentbio.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Cogent Bio (COGT)

- share price and expert price forecast:
General company analysis:cogentbio.com (COGT)
Mass-produced product of Cogent Biosciences Inc

Selecting high-quality issuers is based on analyzing a business's ability to generate real income, where net income per share plays a key role. This rolling net income per share metric measures annual equity income; however, for Cogent Biosciences (COGT), which is currently in the clinical trial stage for oncology, it reflects the capital burn rate prior to FDA approval.

Competitors of Cogent Biosciences (COGT)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|XERS (Xeris Biopharma Holdings, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)